Correction to “[Integration of Circulating Tumor DNA and Metabolic Parameters on 18 F‐Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non‐Small Cell Lung Cancer]”
Source abstract
Abstract
[Leilei Wu; Zhenshan Zhang; Chenxue Jiang; Li Li; Xiaojiang Sun; Menglin Bai; Ming Liu; Kangli Xiong; Jinbiao Shang; Jinming Yu; Shuanghu Yuan; Yang Yang; Yaping Xu; Integration of circulating tumor DNA and metabolic parameters on 18F-Fludeoxyglucose positron emission tomography for outcome prediction in unresectable locally advanced non-small cell lung cancer, Adv Sci, 2025, 12(13): e202413125.] [In paragraph 1 of the “Experimental Section” section, the text “This study was approved by the Ethics Review Committee of Zhejiang Cancer Hospital (No. IRB2012-115).” was incorrect. This should have read: “This study was approved by the Ethics Review Committee of Zhejiang Cancer Hospital (No. IRB-2016-115, with a supplementary approval granted in 2016). Subsequent samples collected after July 2017 were also approved by the Ethics Review Committee of Zhejiang Cancer Hospital (No. IRB-2017-195).”] We apologize for this error.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lung Cancer Diagnosis and Treatment · Radiomics and Machine Learning in Medical Imaging · Lung Cancer Treatments and Mutations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.